Home Barclays Capital Increases Eli Lilly & Co. Price Target to $58.00
 

Keywords :   


Barclays Capital Increases Eli Lilly & Co. Price Target to $58.00

2013-07-28 06:19:29| Biotech - Topix.net

The firm currently has an "equal weight" rating on the stock. Barclays Capital's price objective indicates a potential upside of 8.70% from the company's current price.

Tags: to price capital target

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.10Hurricane Leslie Graphics
05.10Hurricane Leslie Forecast Discussion Number 11
05.10Hurricane Leslie Wind Speed Probabilities Number 11
05.10Hurricane Leslie Public Advisory Number 11
05.10Summary for Hurricane Leslie (AT3/AL132024)
05.10Hurricane Leslie Forecast Advisory Number 11
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 23
More »